These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37695910)

  • 1. Targeting spike glycans to inhibit SARS-CoV2 viral entry.
    Guseman AJ; Rennick LJ; Nambulli S; Roy CN; Martinez DR; Yang DT; Bhinderwala F; Vergara S; Schaefer A; Baric RS; Ambrose Z; Duprex WP; Gronenborn AM
    Proc Natl Acad Sci U S A; 2023 Sep; 120(38):e2301518120. PubMed ID: 37695910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry.
    Guseman AJ; Rennick LJ; Nambulli S; Roy CN; Martinez DR; Yang DT; Bhinderwhala F; Vergara S; Baric RS; Ambrose Z; Duprex WP; Gronenborn AM
    bioRxiv; 2022 Dec; ():. PubMed ID: 36597530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein.
    Nangarlia A; Hassen FF; Canziani G; Bandi P; Talukder C; Zhang F; Krauth D; Gary EN; Weiner DB; Bieniasz P; Navas-Martin S; O'Keefe BR; Ang CG; Chaiken I
    Biochemistry; 2023 Jul; 62(14):2115-2127. PubMed ID: 37341186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses.
    Barre A; Van Damme EJM; Klonjkowski B; Simplicien M; Sudor J; Benoist H; Rougé P
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.
    Barre A; Van Damme EJM; Simplicien M; Le Poder S; Klonjkowski B; Benoist H; Peyrade D; Rougé P
    Cells; 2021 Jun; 10(7):. PubMed ID: 34203435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction.
    Kim CH
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensing the interactions between carbohydrate-binding agents and
    Lokhande KB; Apte GR; Shrivastava A; Singh A; Pal JK; K Venkateswara Swamy ; Gupta RK
    J Biomol Struct Dyn; 2022 Jun; 40(9):3880-3898. PubMed ID: 33292056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycomimetic ligands block the interaction of SARS-CoV-2 spike protein with C-type lectin co-receptors.
    Pollastri S; Delaunay C; Thépaut M; Fieschi F; Bernardi A
    Chem Commun (Camb); 2022 Apr; 58(33):5136-5139. PubMed ID: 35380569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecularly engineered, broad-spectrum anti-coronavirus lectin inhibits SARS-CoV-2 and MERS-CoV infection in vivo.
    Chan JF; Oh YJ; Yuan S; Chu H; Yeung ML; Canena D; Chan CC; Poon VK; Chan CC; Zhang AJ; Cai JP; Ye ZW; Wen L; Yuen TT; Chik KK; Shuai H; Wang Y; Hou Y; Luo C; Chan WM; Qin Z; Sit KY; Au WK; Legendre M; Zhu R; Hain L; Seferovic H; Tampé R; To KK; Chan KH; Thomas DG; Klausberger M; Xu C; Moon JJ; Stadlmann J; Penninger JM; Oostenbrink C; Hinterdorfer P; Yuen KY; Markovitz DM
    Cell Rep Med; 2022 Oct; 3(10):100774. PubMed ID: 36195094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
    Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
    J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.
    Muñoz-Basagoiti J; Monteiro FLL; Krumpe LRH; Armario-Najera V; Shenoy SR; Perez-Zsolt D; Westgarth HJ; Villorbina G; Bomfim LM; Raïch-Regué D; Nogueras L; Henrich CJ; Gallemí M; Moreira FRR; Torres P; Wilson J; D'arc M; Marfil S; Herlinger AL; Pradenas E; Higa LM; Portero-Otin M; Trinité B; Twyman RM; Capell T; Tanuri A; Blanco J; Izquierdo-Useros N; Rech EL; Christou P; O'Keefe BR
    Proc Natl Acad Sci U S A; 2023 Mar; 120(10):e2214561120. PubMed ID: 36853940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pineapple Lectin AcmJRL Binds SARS-CoV-2 Spike Protein in a Carbohydrate-Dependent Fashion.
    Meiers J; Dastbaz J; Adam S; Rasheed S; Kirsch SH; Meiser P; Gross P; Müller R; Titz A
    Chembiochem; 2023 Feb; 24(3):e202200463. PubMed ID: 36420784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin A.
    Klevanski M; Kim H; Heilemann M; Kuner T; Bartenschlager R
    Antiviral Res; 2024 May; 225():105856. PubMed ID: 38447646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Man-Specific, GalNAc/T/Tn-Specific and Neu5Ac-Specific Seaweed Lectins as Glycan Probes for the SARS-CoV-2 (COVID-19) Coronavirus.
    Barre A; Damme EJMV; Simplicien M; Benoist H; Rougé P
    Mar Drugs; 2020 Oct; 18(11):. PubMed ID: 33138151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant lectins as versatile tools to fight coronavirus outbreaks.
    Simplicien M; Pério P; Sudor J; Barre A; Benoist H; Van Damme EJM; Rougé P
    Glycoconj J; 2023 Feb; 40(1):109-118. PubMed ID: 36418811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2.
    Wang WJ; Chen Y; Su WC; Liu YY; Shen WJ; Chang WC; Huang ST; Lin CW; Wang YC; Yang CS; Hou MH; Chou YC; Wu YC; Wang SC; Hung MC
    J Food Biochem; 2022 Oct; 46(10):e14354. PubMed ID: 35894128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Select SARS-CoV-2 N-Linked Glycan and Variant of Concern Spike Protein Mutations on C-Type Lectin-Receptor-Mediated Infection.
    Bains A; Guan W; LiWang PJ
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of N-glycan recognition by pradimicin a and its potential as a SARS-CoV-2 entry inhibitor.
    Nakagawa Y; Fujii M; Ito N; Ojika M; Akase D; Aida M; Kinoshita T; Sakurai Y; Yasuda J; Igarashi Y; Ito Y
    Bioorg Med Chem; 2024 May; 105():117732. PubMed ID: 38643719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycan reactive anti-HIV-1 antibodies bind the SARS-CoV-2 spike protein but do not block viral entry.
    Mannar D; Leopold K; Subramaniam S
    Sci Rep; 2021 Jun; 11(1):12448. PubMed ID: 34127709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.